Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.
Clinical trial NCT04913675 · TERMINATED
Trial details
- NCT number
- NCT04913675
- Sponsor
- Vir Biotechnology, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2022-07-19
- Enrollment
- 1065
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.